Nicholas Investment Partners’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-26,414
Closed -$8.6M 244
2024
Q1
$8.6M Buy
26,414
+15,011
+132% +$3.69M 0.88% 30
2023
Q4
$2.17M Sell
11,403
-54,056
-83% -$10.2M 0.25% 135
2023
Q3
$13M Sell
65,459
-47,540
-42% -$11.2M 0.97% 34
2023
Q2
$32.3M Buy
112,999
+92
+0.1% +$25.5K 2.21% 9
2023
Q1
$24.5M Buy
112,907
+28,400
+34% +$5.53M 1.86% 15
2022
Q4
$17.4M Sell
84,507
-11,269
-12% -$2.85M 1.52% 15
2022
Q3
$26.6M Sell
95,776
-4,727
-5% -$1.2M 2.47% 2
2022
Q2
$19.2M Buy
+100,503
New +$17.7M 1.82% 8

Other funds holding SWAV

Nicholas Investment Partners's SWAV Position: Q2 2024 in Review

Nicholas Investment Partners sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 26,414 shares — an estimated $8.6M sold.

Nicholas Investment Partners first reported a position in SWAV in Q2 2022 and held it in 8 quarters. The position peaked at $32.3M in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Nicholas Investment Partners reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Nicholas Investment Partners sold 26,414 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $8.6M.
  • Nicholas Investment Partners first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Nicholas Investment Partners's Shockwave Medical, Inc. Common Stock position peaked at $32.3M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Nicholas Investment Partners's 13F filing for Q2 2024, filed 8 Aug 2024.